9th Annual Monitoring & Patient Recruitment Retention (CMPRR) Summit

November 15, 2023
November 16, 2023
CET
NH Barcelona Stadium 4*, Travessera de les Corts, 150, 152, 08028 Barcelona, Spain

CMPRR Summit is targeted at professionals who seek new opportunities and visionary ways of improving clinical trial performance. The two days will cover a range of challenges facing clinical professionals in the current climate, such as communication quality, role of technologies in clinical innovation, quality standards, compliance oversight and new approaches to patient engagement. Valdo Arnera, M.D., Medical Scientific Advisor in the eCOA Science team, will discuss the consequences of the FDA PFDD Guidance 3, the importance of ensuring High Quality Measurements and will highlight the results of industry-first scientific research to improve the patient experience.

Session information:

Title: How accessibility functionality paves the way for increased trial participation

Date: Wednesday, November 15, 2023

Time: 12:00 CET

Abstract

Valdo will discuss the consequences of the FDA PFDD Guidance 3, the importance of ensuring High Quality Measurements and will present industry-first scientific research to improve the patient experience.

Speaker

Valdo Arnera, M.D.

Medical Scientific Advisor and General Manager Geneva Office at Clario

A Medical Doctor by training, Valdo has over 35 years of experience in the pharmaceutical industry. Starting his career as a clinical pharmacologist in a Ciba-Geigy’s daughter company, he then founded the first European Central clinical laboratory dedicated to clinical trials, SciCor (now Labcorp Drug Development). Always passionate about how to improve the clinical trial process, Valdo joined PHT in 2000, and founded the European affiliate of PHT Corporation in January 2001. PHT was acquired by ERT in 2015 and then merged with Bioclinica to form Clario. Valdo has always taken care of the eCOA portion of Clario and is seen as one of the pioneers of the ePRO business.